Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil
- PMID: 1978306
- DOI: 10.1023/a:1015912932416
Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil
Abstract
The permeation of fentanyl and sufentanil through cadaver skin membranes was investigated using in vitro diffusion cell techniques. Neither drug influenced the permeation of the other when they were concurrently applied to the skin membrane. With respect to transdermal delivery, short diffusion lag times of less than 0.5 hr were observed for each compound. Their permeation rates through heat-isolated epidermis and dermatomed (200- to 250-microns) skin sections were essentially the same. However, when the stratum corneum was removed by tape stripping, the respective permeability coefficients were increased greater than 30-fold, establishing the stratum corneum as the principal barrier to their skin permeation. Permeation was also studied as a function of pH. From pH 4 to pH 8 the permeability coefficients of both fentanyl and sufentanil, calculated from the total solution concentration regardless of ionization, increased exponentially. The free base is thus responsible for the relatively facile skin permeation of these drugs. Factoring of the independent permeability coefficients of the ionized and free-base forms was possible, with the latter being over two log orders larger than seen for the protonated species. Permeability coefficients of fentanyl and sufentanil through skin sections obtained from different cadavers varied four- to fivefold. Neither gender nor age was a flux-determining variable for either drug. The permeability coefficients of the drugs through skin sites as diverse as the sole of the foot, chest, thigh, and abdomen were remarkably similar. Their fluxes were sufficient for transdermal administration.
Similar articles
-
Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin.J Pharm Sci. 1994 Dec;83(12):1723-8. doi: 10.1002/jps.2600831215. J Pharm Sci. 1994. PMID: 7891301
-
Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin.Pharm Res. 1989 Oct;6(10):825-32. doi: 10.1023/a:1015944018555. Pharm Res. 1989. PMID: 2575255
-
Transdermal delivery of fentanyl from matrix and reservoir systems: effect of heat and compromised skin.J Pharm Sci. 2010 May;99(5):2357-66. doi: 10.1002/jps.22004. J Pharm Sci. 2010. PMID: 19967778
-
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.Clin Pharmacokinet. 1996 Oct;31(4):275-92. doi: 10.2165/00003088-199631040-00004. Clin Pharmacokinet. 1996. PMID: 8896944 Review.
-
The transdermal delivery of fentanyl.Eur J Pharm Biopharm. 2013 Aug;84(3):449-55. doi: 10.1016/j.ejpb.2013.01.018. Epub 2013 Feb 16. Eur J Pharm Biopharm. 2013. PMID: 23419814 Review.
Cited by
-
Death by band-aid: fatal misuse of transdermal fentanyl patch.Int J Legal Med. 2015 Nov;129(6):1247-52. doi: 10.1007/s00414-015-1209-z. Epub 2015 Jun 9. Int J Legal Med. 2015. PMID: 26055040
-
Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line.Support Care Cancer. 2010 Jun;18(6):761-4. doi: 10.1007/s00520-010-0869-y. Epub 2010 Mar 31. Support Care Cancer. 2010. PMID: 20354734
-
Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.Drugs. 2001;61(15):2289-307. doi: 10.2165/00003495-200161150-00014. Drugs. 2001. PMID: 11772140 Review.
-
Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.Drug Saf. 2003;26(13):951-73. doi: 10.2165/00002018-200326130-00004. Drug Saf. 2003. PMID: 14583070 Review.
-
[Transdermal fentanyl for the treatment of cancer pain.].Schmerz. 1993 Mar;7(1):18-24. doi: 10.1007/BF02527634. Schmerz. 1993. PMID: 18415415 German.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources